Clinical Genomics & Diagnostic Applications
Session Overview
The translation of genomic discoveries into routine clinical practice is reshaping modern medicine. This session focuses on the practical implementation of genomic technologies within healthcare systems, moving from foundational research to validated diagnostic and therapeutic tools. We will examine the entire clinical genomics pathway—from assay selection and result generation to interpretation, reporting, and guiding patient management—addressing the critical challenges and standards necessary for safe, effective, and equitable integration into patient care.
Why This Session Matters Now
Genomic medicine is rapidly transitioning from a specialized service to a core component of diagnostics in oncology, rare disease, pharmacotherapy, and more. This expansion brings to the forefront essential questions of scalability, accuracy, interpretation, and clinical utility. Successfully navigating this transition requires harmonizing technological innovation with rigorous clinical validation, robust laboratory standards, and clear guidelines for actionability. This session addresses the multidisciplinary expertise needed to bridge the gap between the promise of genomics and its responsible, real-world application at the patient bedside.
Key Scientific and Clinical Themes
Clinical whole genome/exome sequencing implementation
Discussing strategies for the effective adoption of comprehensive genomic sequencing in diagnostic pipelines, including test selection, informed consent, and integration with existing clinical workflows for rare diseases and cancer.
Liquid biopsy and circulating tumor DNA diagnostics
Exploring the evolving role of minimally invasive liquid biopsies in oncology for detection, monitoring, treatment selection, and understanding resistance mechanisms, alongside considerations for analytical sensitivity and clinical validation.
Variant interpretation and classification guidelines
Examining the complex frameworks and international standards for determining the clinical significance of genomic variants, a foundational step for accurate diagnosis and actionable reporting.
Pharmacogenomics and treatment optimization
Focusing on the integration of genetic information to guide drug selection and dosing, aiming to maximize efficacy and minimize adverse drug reactions across therapeutic areas.
Rapid and point-of-care genomic testing
Assessing emerging technologies and workflows that deliver genomic results in critical time-sensitive settings, such as acute care, neonatal intensive care, and during surgical procedures.
Laboratory infrastructure and quality frameworks
Addressing the essential pillars of a clinical genomics service, including laboratory accreditation, proficiency testing, bioinformatics pipeline validation, data security, and the total quality management systems required for reliable testing.
Nature of Research in This Field
Research in clinical genomics is fundamentally translational and applied. It encompasses clinical validation studies, health outcomes research, health economics, and the development of professional guidelines. This work is characterized by strong collaboration between clinical laboratory scientists, bioinformaticians, genetic counselors, physicians (oncologists, geneticists, pathologists), ethicists, and health system administrators. The field prioritizes evidence generation, standardization, and the creation of practical tools and frameworks that ensure patient safety, result reliability, and clear clinical utility.
Who Should Attend
This session is designed for:
- Molecular pathologists, clinical geneticists, and laboratory directors.
- Oncologists, pharmacists, and clinicians implementing genomic-guided therapy.
- Clinical bioinformaticians and scientists in diagnostic laboratories.
- Hospital administrators and healthcare policy professionals.
- Genetic counselors and clinical genomics coordinators.
- Professionals from diagnostic and biotech companies developing clinical assays.
- Researchers focused on translational genomics and clinical trial design.
Session Perspective
“Clinical Genomics & Diagnostic Applications” is dedicated to the principle that a genomic finding is only as valuable as the clinical action it informs. This session emphasizes that implementing genomics in healthcare is as much a challenge of systems, standards, and interpretation as it is of technology. By convening experts across the diagnostic ecosystem, this session examines the essential frameworks required to ensure genomic medicine is practiced with accuracy, consistency, and ethical responsibility, supporting its potential to improve outcomes across the spectrum of human disease.
If your research aligns with this session, we invite you to submit an abstract for consideration.
